Expand Screening for HCV infection in all adults living in the US?

MEDPAGE TODAY
Gastroenterology > Hepatitis 
Time to Expand Age Base for HCV Screening? 
Bargain price of $11,378 per QALY gained for one-time, universal testing
by Diana Swift, Contributing Writer September 15, 2018

Compared with currently recommended birth cohort screening, universal one-time screening for hepatitis C virus (HCV) for U.S. adults would be highly cost-effective, resulting in an expenditure of $11,378 per quality-adjusted life year (QALY) gained, researchers reported

The findings support broadening the current age cohort for one-time screening to all U.S. adults, concluded Mark H. Eckman, MD, of the University of Cincinnati, and colleagues. "A recommendation for HCV testing of all adults will support the national response to the epidemic of HCV infection among young persons in the United States."

Continue reading:

 https://www.medpagetoday.com/gastroenterology/hepatitis/75118

Primary Source

Clinical Gastroenterology and Hepatology

Source Reference: Eckman MH, et al “Cost effectiveness of universal screening for HCV infection in the era of direct-acting, pangenotypic treatment regimens” Clin Gastroenterol Hepatol 2018. DOI: 10.1016/j.cgh.2018.08.080.